Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Protein > BCMA > BCA-H522y

Human BCMA / TNFRSF17 Protein, His Tag, premium gradeDMF

Order Now

  • Synonym
    TNFRSF17,CD269,BCM,BCMA
  • Source
    Human BCMA, His Tag, premium grade(BCA-H522y) is expressed from human 293 cells (HEK293). It contains AA Met 1 - Ala 54 (Accession # Q02223-1 ).
    Predicted N-terminus: Met 1
    It is produced under our rigorous quality control system that incorporates a comprehensive set of tests including sterility and endotoxin tests. Product performance is carefully validated and tested for compatibility for cell culture use or any other applications in the early preclinical stage. When ready to transition into later clinical phases, we also offer a custom GMP protein service that tailors to your needs. We will work with you to customize and develop a GMP-grade product in accordance with your requests that also meets the requirements for raw and ancillary materials use in cell manufacturing of cell-based therapies.
  • Molecular Characterization
    BCMA Structure

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 7.8 kDa. The protein migrates as 12 kDa and 14-18 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin
    Less than 0.01 EU per μg by the LAL method.
  • Sterility
    The sterility testing was performed by membrane filtration method.
  • Mycoplasma
    Negative.
  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 24 months in lyophilized state;
    2. -70°C for 12 months under sterile conditions after reconstitution.
SDS-PAGE
BCMA SDS-PAGE

Human BCMA, His Tag, premium grade on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90%.

SEC-HPLC
BCMA SEC-HPLC

The purity of Human BCMA, His Tag, premium grade (Cat. No. BCA-H522y) was greater than 80% as determined by SEC-HPLC.

Bioactivity-FACS
 BCMA FACS

2e5 of BCMA-CAR-293 cells transfected with anti-BCMA-scFv were stained with 100 μL of 0.3 μg/mL of Human BCMA, His Tag, premium grade (Cat. No. BCA-H522y) and negative control protein respectively, washed and then followed by FITC anti-6xHis tag antibody and analyzed with FACS (Routinely tested).

Bioactivity-ELISA
 BCMA ELISA

Immobilized Human BAFF, Fc Tag (Cat. No. BAF-H4268) at 5 μg/mL (100 μL/well) can bind Human BCMA, His Tag, premium grade (Cat. No. BCA-H522y) with a linear range of 0.031-0.5 μg/mL (QC tested).

 BCMA ELISA

Immobilized Human APRIL, Fc Tag (Cat. No. APL-H5267) at 5 μg/mL (100 μL/well) can bind Human BCMA, His Tag, premium grade (Cat. No. BCA-H522y) with a linear range of 6-25 ng/mL (Routinely tested).

 BCMA ELISA

Immobilized Human BCMA, His Tag, premium grade (Cat. No. BCA-H522y) at 2 μg/mL (100 μL/well) can bind Monoclonal Anti-Human BCMA Antibody, Human IgG1 with a linear range of 0.2-3 ng/mL (Routinely tested).

 BCMA ELISA

Immobilized Human BCMA, His Tag, premium grade (Cat. No. BCA-H522y) at 2 μg/mL (100 μL/well) can bind Anti-BCMA Neutralizing Antibody, Mouse IgG1 with a linear range of 0.2-3 ng/mL (Routinely tested).

Bioactivity-SPR
 BCMA SPR

Anti-Human BCMA MAb (human IgG1) captured on CM5 chip via Anti-Human IgG Fc antibodies surface, can bind Human BCMA, His Tag, premium grade (Cat. No. BCA-H522y) with an affinity constant of 13.0 nM as determined in a SPR assay (Biacore T200) (Routinely tested).

 BCMA SPR

Anti-BCMA Neutralizing Antibody, Mouse IgG1 captured on CM5 chip via anti-mouse antibodies surface can bind Human BCMA, His Tag, premium grade (Cat. No. BCA-H522y) with an affinity constant of 0.234 nM as determined in a SPR assay (Biacore T200) (Routinely tested).

Bioactivity-BLI
 BCMA BLI

Loaded Anti-Human BCMA MAb (human IgG1) on Protein A Biosensor, can bind Human BCMA, His Tag, premium grade (Cat. No. BCA-H522y) with an affinity constant of 29.1 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

 BCMA BLI

Loaded Human APRIL, Fc Tag (Cat. No. APL-H5267) on Protein A Biosensor, can bind Human BCMA, His Tag, premium grade (Cat. No. BCA-H522y) with an affinity constant of 10.9 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

 BCMA BLI

Loaded Human BAFF, Fc Tag (Cat. No. BAF-H4268) on Protein A Biosensor, can bind Human BCMA, His Tag, premium grade (Cat. No. BCA-H522y) with an affinity constant of 0.64 μM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

  • Background
    Tumor necrosis factor receptor superfamily member 17 (TNFRSF17) is also known as B-cell maturation protein (BCMA), CD antigen CD269, which is a member of the TNF-receptor superfamily. TNFRSF17 contains one TNFR-Cys repeat. TNFRSF17 is expressed in mature B-cells, but not in T-cells or monocytes. TNFRSF17 is receptor for TNFSF13B/BLyS/BAFF and TNFSF13/APRIL. TNFRSF17 promotes B-cell survival and plays a role in the regulation of humoral immunity. TNFRSF17 can activate NF-kappa-B and JNK.
  • Clinical and Translational Updates

Comments (0)


ETD of in-stock products: 2 business days

Price(USD) : $385.00

Price(USD) : $2640.00

Recommended Products
Monoclonal Anti-His Tag Antibody

Price(USD) : $240.00

Price(USD) : $1580.00

HRP conjugated Anti-His Tag Antibody

Price(USD) : $250.00

Price(USD) : $1680.00

Promotion & Exhibitions



Drug Development Status

  • Number of Launched Drugs:6 Details
  • Number of Drugs in Clinical Trials:89 Details
  • Latest Research Phase:Approved

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Related Products

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message